Total Payments
$1.6M
2024 Payments
$156,112
Companies
30
Transactions
1,287
Medicare Patients
1,557
Medicare Billing
$296,876
Payment Breakdown by Category
Consulting$1.1M (72.1%)
Other$294,151 (18.8%)
Travel$84,665 (5.4%)
Food & Beverage$40,932 (2.6%)
Education$11,640 (0.7%)
Research$6,600 (0.4%)
Gifts$106.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.1M | 320 | 72.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $106,750 | 32 | 6.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $96,175 | 31 | 6.1% |
| Travel and Lodging | $84,665 | 256 | 5.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $52,400 | 22 | 3.3% |
| Food and Beverage | $40,932 | 601 | 2.6% |
| Honoraria | $38,800 | 19 | 2.5% |
| Education | $11,640 | 3 | 0.7% |
| Unspecified | $6,600 | 1 | 0.4% |
| Gift | $106.00 | 1 | 0.0% |
| Entertainment | $26.43 | 1 | 0.0% |
Payments by Type
General
$1.6M
1,286 transactions
Research
$6,600
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $835,565 | 701 | $0 (2024) |
| Cardiovascular Systems Inc. | $207,883 | 141 | $0 (2023) |
| Boston Scientific Corporation | $141,039 | 115 | $0 (2024) |
| ShockWave Medical, Inc | $75,272 | 67 | $0 (2024) |
| Philips Electronics North America Corporation | $58,366 | 68 | $0 (2023) |
| Teleflex LLC | $49,288 | 35 | $0 (2024) |
| Cardinal Health 200 LLC | $46,069 | 36 | $0 (2021) |
| ABIOMED | $36,416 | 36 | $0 (2023) |
| ARIAD Pharmaceuticals, Inc. | $27,075 | 3 | $0 (2017) |
| Arrow International, Inc. | $22,305 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $156,112 | 170 | Abbott Laboratories ($59,538) |
| 2023 | $270,611 | 194 | Abbott Laboratories ($157,728) |
| 2022 | $250,336 | 153 | Abbott Laboratories ($102,645) |
| 2021 | $99,572 | 80 | Cardiovascular Systems Inc. ($54,531) |
| 2020 | $201,978 | 148 | Abbott Laboratories ($142,735) |
| 2019 | $177,290 | 199 | Abbott Laboratories ($125,935) |
| 2018 | $273,337 | 243 | Abbott Laboratories ($152,954) |
| 2017 | $138,461 | 100 | Abbott Laboratories ($91,404) |
All Payment Transactions
1,287 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Abbott Laboratories | ULTREON (Device) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Vascular | ||||||
| 12/30/2024 | Abbott Laboratories | ULTREON (Device) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: Vascular | ||||||
| 12/27/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: General - Therapies_IC | ||||||
| 12/27/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $2,187.50 | General |
| Category: General - Structural Heart_IC | ||||||
| 12/27/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| Category: General - Therapies_IC | ||||||
| 12/23/2024 | Abbott Laboratories | ULTREON (Device) | Food and Beverage | In-kind items and services | $98.74 | General |
| Category: Vascular | ||||||
| 12/23/2024 | Abbott Laboratories | ULTREON (Device) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Vascular | ||||||
| 12/19/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: General - Structural Heart_IC | ||||||
| 12/19/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: General - Stents_IC | ||||||
| 12/19/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Travel and Lodging | In-kind items and services | $881.80 | General |
| Category: Vascular | ||||||
| 12/19/2024 | Boston Scientific Corporation | — | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| Category: General - Structural Heart_IC | ||||||
| 12/19/2024 | Abbott Laboratories | XIENCE SKYPOINT (Device) | Travel and Lodging | In-kind items and services | $380.00 | General |
| Category: Vascular | ||||||
| 12/13/2024 | Arrow International, Inc. | TURNPIKE (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,750.00 | General |
| Category: INTERVENTIONAL ACCESS | ||||||
| 12/13/2024 | Arrow International, Inc. | GUIDELINER (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,000.00 | General |
| Category: INTERVENTIONAL ACCESS | ||||||
| 12/13/2024 | Arrow International, Inc. | GUIDELINER (Device) | Travel and Lodging | Cash or cash equivalent | $62.00 | General |
| Category: INTERVENTIONAL ACCESS | ||||||
| 12/13/2024 | Arrow International, Inc. | GUIDELINER (Device) | Travel and Lodging | Cash or cash equivalent | $55.56 | General |
| Category: INTERVENTIONAL ACCESS | ||||||
| 12/13/2024 | Arrow International, Inc. | TURNPIKE (Device) | Travel and Lodging | Cash or cash equivalent | $50.00 | General |
| Category: INTERVENTIONAL ACCESS | ||||||
| 12/12/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: General - Vascular Access_IC | ||||||
| 12/12/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: General - Vascular Access_IC | ||||||
| 12/11/2024 | Abbott Laboratories | OPTIS (Device) | Consulting Fee | Cash or cash equivalent | $18,200.00 | General |
| Category: Vascular | ||||||
| 12/11/2024 | Abbott Laboratories | OPTIS (Device) | Consulting Fee | Cash or cash equivalent | $18,200.00 | General |
| Category: Vascular | ||||||
| 12/11/2024 | Philips North America LLC | (9520) IGT Devices Undivided (Device) | Consulting Fee | Cash or cash equivalent | $5,000.00 | General |
| Category: Medical Device | ||||||
| 12/11/2024 | Abbott Laboratories | OPTIS (Device) | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| Category: Vascular | ||||||
| 12/11/2024 | Abbott Laboratories | OPTIS (Device) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Vascular | ||||||
| 12/11/2024 | Abbott Laboratories | OPTIS (Device) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Vascular | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PHASE II STUDY OF THE COMBINATION OF BLINATUMOMAB AND PONATINIB IN PATIENTS WITH PHILADELPHIA CHROMOSOME (PH)-POSITIVE AND/OR BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) | Takeda Pharmaceuticals U.S.A., Inc. | $6,600 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 366 | 421 | $388,961 | $67,852 |
| 2022 | 17 | 450 | 520 | $501,796 | $90,236 |
| 2021 | 15 | 376 | 410 | $371,235 | $68,656 |
| 2020 | 15 | 365 | 407 | $369,146 | $70,132 |
Total Patients
1,557
Total Services
1,758
Medicare Billing
$296,876
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 44 | 58 | $137,210 | $24,022 | 17.5% |
| 92943 | Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | Facility | 2023 | 14 | 17 | $45,184 | $8,038 | 17.8% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 50 | 51 | $49,125 | $7,632 | 15.5% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 75 | 84 | $32,044 | $6,517 | 20.3% |
| 92920 | Balloon dilation of single coronary artery or branch | Facility | 2023 | 14 | 17 | $36,135 | $4,784 | 13.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 27 | 32 | $19,168 | $3,647 | 19.0% |
| 92974 | Insertion of radiation delivery device into heart artery | Facility | 2023 | 23 | 27 | $17,496 | $3,546 | 20.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 38 | 45 | $13,725 | $2,971 | 21.6% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 11 | 11 | $13,046 | $2,022 | 15.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 22 | $8,876 | $1,477 | 16.6% |
| 92979 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | Facility | 2023 | 16 | 22 | $6,697 | $1,362 | 20.3% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 21 | 21 | $7,959 | $1,247 | 15.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 14 | $2,296 | $586.18 | 25.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 44 | 63 | $152,306 | $26,149 | 17.2% |
| 92943 | Removal of plaque, insertion of stent and/or balloon dilation of single coronary artery, branch or bypass graft | Facility | 2022 | 19 | 20 | $54,316 | $10,329 | 19.0% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2022 | 57 | 59 | $57,851 | $8,916 | 15.4% |
| 92933 | Removal of plaque, insertion of stent and balloon dilation of single coronary artery or branch | Facility | 2022 | 13 | 14 | $38,484 | $7,788 | 20.2% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2022 | 79 | 93 | $34,902 | $7,446 | 21.3% |
| 92920 | Balloon dilation of single coronary artery or branch | Facility | 2022 | 11 | 17 | $36,736 | $5,837 | 15.9% |
| 92974 | Insertion of radiation delivery device into heart artery | Facility | 2022 | 26 | 32 | $21,096 | $4,355 | 20.6% |
| 93455 | Insertion of tube in bypass graft for diagnosis with review by radiologist | Facility | 2022 | 17 | 18 | $20,594 | $3,172 | 15.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 37 | 45 | $12,784 | $2,743 | 21.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 37 | 46 | $13,354 | $2,721 | 20.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 19 | 21 | $12,323 | $2,076 | 16.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 13 | 13 | $9,885 | $1,894 | 19.2% |
About Kevin Croce, MD, PHD
Kevin Croce, MD, PHD is a Cardiovascular Disease healthcare provider based in Chestnut Hill, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417983172.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kevin Croce, MD, PHD has received a total of $1.6M in payments from pharmaceutical and medical device companies, with $156,112 received in 2024. These payments were reported across 1,287 transactions from 30 companies. The most common payment nature is "Consulting Fee" ($1.1M).
As a Medicare-enrolled provider, Croce has provided services to 1,557 Medicare beneficiaries, totaling 1,758 services with total Medicare billing of $296,876. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Chestnut Hill, MA
- Active Since 06/24/2006
- Last Updated 09/28/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1417983172
Products in Payments
- Xience V coronary stent system (Device) $222,356
- OPTIS (Device) $216,802
- PCI Optimization (Device) $126,263
- Optis Coronary Imaging System (Device) $99,356
- Diamondback Coronary (Device) $90,262
- DRAGONFLY OPSTAR (Device) $89,782
- Coronary Orbital Atherectomy System (Device) $57,751
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $52,470
- Dragonfly OCT (Device) $45,469
- CROSSBOSS (Device) $38,133
- Impella (Device) $36,275
- TURNPIKE (Device) $28,555
- AVVIGO Guidance System (Device) $28,489
- Iclusig (Drug) $27,075
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $22,581
- GUIDELINER (Device) $21,788
- (9520) IGT Devices Undivided (Device) $18,917
- Belviq (Drug) $13,300
- (9017) CVX-300 (Device) $11,448
- GENERAL - THERAPIES (Device) $7,495
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.